...
首页> 外文期刊>British Journal of Cancer >Possibility of in vitro Alterations in Cultures of Mammary Carcinoma Cells, and Altered Immunological Response in the Rat: Acquired Capacity to Reject Injections of Mammary Carcinoma Cells and Implants of Mammary Carcinoma
【24h】

Possibility of in vitro Alterations in Cultures of Mammary Carcinoma Cells, and Altered Immunological Response in the Rat: Acquired Capacity to Reject Injections of Mammary Carcinoma Cells and Implants of Mammary Carcinoma

机译:乳腺癌细胞培养物中体外变化的可能性以及大鼠免疫反应的改变:获得的拒绝乳癌细胞和乳癌植入物的能力

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Cell cultures derived from a mammary adenocarcinoma carried in inbred Fisher (CDF) strain female rats, have been shown to possess oncogenic activities and on injection into control rats to produce mammary carcinomata with a failure rate of only one out of 25 rats (i.e. 4%). Efforts have been made to alter the cultured cells, or to select populations from them, so that the response in rats to their antigenic characteristics might leave them with the ability to then reject injections of the active, untreated cancer cells. We have found that continuous treatment of the cultures by their own cell debris (sonicate), or by relatively high concentrations of intact, salmon-sperm DNA, lead to cell populations which have a decreased potential to produce mammary carcinomata, with a combined failure rate of 9 out of 12 rats (i.e. 75%): 5 out of these 12 rats (i.e. 41·7%) did not exhibit any growth (carcinomata or granulomata) after injection of these treated cells, and now all 5 (i.e. 100%) have the capacity to reject injections of the untreated, active cancer cells. Four of these rats (one died under anaesthesia) have now been found to also reject implants of the carcinoma itself.
机译:已证明自交费舍尔(CDF)雌性大鼠所携带的源自乳腺腺癌的细胞培养物具有致癌活性,并且在注入对照大鼠中产生乳腺癌时,其失败率仅为25只大鼠中的一只(即4%) )。已经做出了改变培养的细胞或从其中选择群体的努力,以便大鼠对它们的抗原特性的反应可能使它们具有拒绝随后注射未经处理的活性癌细胞的能力。我们发现,通过培养物自身的细胞碎片(超声处理)或相对较高浓度的完整鲑鱼精DNA连续处理培养物,导致细胞群体产生乳癌的可能性降低,且合并失败率高12只大鼠中有9只(即75%):在注射这些处理过的细胞后,这12只大鼠中有5只(即41·7%)没有任何生长(癌瘤或肉芽肿),现在所有5只(即100%) )有能力拒绝未经治疗的活跃癌细胞的注射。现在,已经发现其中四只大鼠(一只在麻醉下死亡)也排斥了癌症本身的植入物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号